Monday, August 17, 2009

Swine Flu Shot May Rely on Emergency Use of Additives

Swine flu vaccine makers may rely on a U.S. emergency declaration to use experimental additives made by GlaxoSmithKline Plc and Novartis AG to boost a limited supply of shots that will be available to fight the pandemic.
FULL STORY HERE:
http://www.bloomberg.com/apps/news?pid=20601103&sid=alZncUEvwtIM